Latest California Healthline Stories
Can Drug Price Transparency Keep Costs Down?
California is among a number of states considering new laws to control the rising cost of prescription medications.
Medical Marijuana Linked To Modest Budget Benefits For Medicare Part D, Study Finds
A Health Affairs study determines that Part D spending went down slightly on prescription drugs for which medical marijuana is viewed as a possible alternative.
Sounds Like A Good Idea? Regulating Drug Prices
Presidential candidates from both parties have proposals they say would help lower the cost of prescription drugs. But most experts say that efforts to regulate prices might not end up saving much money.
California Drug Price Transparency Bill Clears Key Committee
The controversial measure was amended to address drugmakers’ concerns; some lawmakers were confused by the legislation.
Medi-Cal gastará cerca de mil millones en drogas para la hepatitis C el próximo año
En total, el gasto en hepatitis C está aumentando porque más personas están tomando los costosos medicamentos nuevos. Pero el costo por paciente está bajando.
California Drug Price Measure Fiercely Opposed By Pharmaceutical Industry
Proposed legislation would require drugmakers to disclose and justify price hikes. The industry has taken to Facebook and Twitter, warning that the proposal could lead to medication shortages in some regions of the state.
Medi-Cal To Spend Nearly $1 Billion On Hepatitis C Drugs Next Year
Costly meds will be discussed at lawmaker hearing on controversial drug price transparency bill.
Report From Key Agency Raises Concerns About Proposal To Cut Drug Prices
Staff researchers at California’s largest public buyer of health benefits say the goal of reducing drug costs for the state is appealing but might not work in the real world.
State Legislators Push Bill To Inform Patients Of Drug Company Discount Programs
Opponents of the proposal say a requirement to inform consumers of such programs would only boost drug company sales and increase overall health care spending.
Medicare’s Drug-Pricing Experiment Stirs Opposition
A proposal to change the way Medicare pays for some drugs has set off intense reaction and lobbying — all tied to a common theme: How far should the government go in setting prices for prescription drugs?